
### [DOID:440](http://purl.obolibrary.org/obo/DOID_440)
**Label:** neuromuscular disease

**Subclasses:** [DOID:437](http://purl.obolibrary.org/obo/DOID_437) (myasthenia gravis), [DOID:0050539](http://purl.obolibrary.org/obo/DOID_0050539) (Charcot-Marie-Tooth disease type 2), [DOID:0050541](http://purl.obolibrary.org/obo/DOID_0050541) (Charcot-Marie-Tooth disease type 4), [DOID:3635](http://purl.obolibrary.org/obo/DOID_3635) (congenital myasthenic syndrome), [DOID:10595](http://purl.obolibrary.org/obo/DOID_10595) (Charcot-Marie-Tooth disease), [DOID:0050542](http://purl.obolibrary.org/obo/DOID_0050542) (Charcot-Marie-Tooth disease type X), 

**Corr. equiv. classes:** [OMIM:118230](http://purl.obolibrary.org/obo/OMIM_118230), [OMIM:PS601462](http://purl.obolibrary.org/obo/OMIM_PS601462), [Orphanet:590](http://www.orpha.net/ORDO/Orphanet_590), [Orphanet:64746](http://www.orpha.net/ORDO/Orphanet_64746), [Orphanet:64747](http://www.orpha.net/ORDO/Orphanet_64747), [OMIM:PS118220](http://purl.obolibrary.org/obo/OMIM_PS118220), [Orphanet:64749](http://www.orpha.net/ORDO/Orphanet_64749), [OMIM:604484](http://purl.obolibrary.org/obo/OMIM_604484), [OMIM:254200](http://purl.obolibrary.org/obo/OMIM_254200), 

**Class expressions from DL-Learner:**

- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 47.29%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 41.67%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 38.32%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 34.72%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 34.72%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 33.03%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 31.10%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) 30.19%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 26.35%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 25.33%
- [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 24.78%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 23.71%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 23.07%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 20.90%
- Thing 20.88%


